NT5E and brain neoplasm: To confirm these findings and better understand this pediatric subgroup, we analyzed CD73 mRNA and protein expression in a cohort of 102 pediatric brain tumor specimens (from 69 patients) obtained from the Children’s Brain Tumor Tissue Consortium (CBTTC)62.